BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37201530)

  • 1. Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype.
    Natorska J; Corral J; de la Morena-Barrio ME; Bravo-Pérez C; Bagoly Z; Bereczky Z; Treliński J; Witkowski M; Klajmon A; Undas A; Ząbczyk M
    Thromb Haemost; 2023 Sep; 123(9):880-891. PubMed ID: 37201530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
    Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
    J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk.
    Ząbczyk M; Natorska J; Janion-Sadowska A; Metzgier-Gumiela A; Polak M; Plens K; Janion M; Skonieczny G; Mizia-Stec K; Undas A
    Sci Rep; 2020 Jul; 10(1):11433. PubMed ID: 32651425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
    Matusik PT; Matusik PS; Kornacewicz-Jach Z; Małecka B; Ząbek A; Undas A
    Int J Cardiol; 2017 Sep; 243():244-250. PubMed ID: 28571619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis.
    Goldman S; Frączek P; Szklanny K; Papuga-Szela E; Stanisz A; Undas A
    Thromb Haemost; 2018 Apr; 118(4):654-663. PubMed ID: 29618152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin clot properties among women with endometriosis and the impact of ovarian stimulation.
    Piróg M; Kacalska-Janssen O; Jach R; Ząbczyk M; Natorska J
    Reprod Biomed Online; 2021 Jul; 43(1):81-90. PubMed ID: 34001444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade endotoxemia in acute pulmonary embolism: Links with prothrombotic plasma fibrin clot phenotype.
    Ząbczyk M; Kruk A; Natorska J; Undas A
    Thromb Res; 2023 Dec; 232():70-76. PubMed ID: 37949000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
    Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
    Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease.
    Paszek E; Malinowski KP; Ząbczyk M; Butenas S; Undas A
    Eur J Clin Invest; 2023 Sep; 53(9):e14007. PubMed ID: 37042848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombotic alterations in plasma fibrin clot properties in thyroid disorders and their post-treatment modifications.
    Mazur P; Sokołowski G; Hubalewska-Dydejczyk A; Płaczkiewicz-Jankowska E; Undas A
    Thromb Res; 2014 Aug; 134(2):510-7. PubMed ID: 24962680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome.
    Siudut J; Grela M; Wypasek E; Plens K; Undas A
    J Thromb Haemost; 2016 Apr; 14(4):784-93. PubMed ID: 26786481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
    Drabik L; Wołkow P; Undas A
    Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation.
    Gronostaj K; Richter P; Nowak W; Undas A
    Thromb Res; 2013 Mar; 131(3):262-7. PubMed ID: 23273404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRH Antagonist Protocol Enhances Coagulation During Controlled Ovarian Stimulation for IVF.
    Piróg M; Kacalska-Janssen O; Jach R; Wyroba J; Chrostowski B; Ząbczyk M; Natorska J
    Reprod Sci; 2022 Dec; 29(12):3521-3531. PubMed ID: 35821349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombotic fibrin clot properties are associated with post-discharge venous thromboembolism in acutely ill medical patients.
    Wójcik M; Zaręba L; Undas A
    Thromb Res; 2019 Oct; 182():141-149. PubMed ID: 31479942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced plasma fibrin clot permeability and susceptibility to fibrinolysis are associated with increased intima-media thickness in patients with primary antiphospholipid syndrome.
    Asztabski M; Wypasek E; Ząbczyk M; Undas A
    Thromb Res; 2014 Nov; 134(5):945-51. PubMed ID: 25194881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.
    Zabczyk M; Plens K; Wojtowicz W; Undas A
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):365-373. PubMed ID: 28062504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fibrin clot proteomics in patients with acute pulmonary embolism: Association with clot properties.
    Bryk AH; Natorska J; Ząbczyk M; Zettl K; Wiśniewski JR; Undas A
    J Proteomics; 2020 Oct; 229():103946. PubMed ID: 32810596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
    Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Podolak-Dawidziak M; Kuliczkowski K
    Eur J Clin Invest; 2014 Jun; 44(6):557-66. PubMed ID: 24738991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.